The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.
Clinical trial NCT03156504 · COMPLETED
Trial details
- NCT number
- NCT03156504
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2020-02-12
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.